PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 7530605-0 1995 TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion. Diethylnitrosamine 60-78 transforming growth factor alpha Rattus norvegicus 0-9 7586202-9 1995 There was pronounced bile duct proliferation in DEN/TCDD treated animals after the waiting period with intense expression of TGF alpha in bile duct epithelial cells at detected by immunohistochemical methods. Diethylnitrosamine 48-51 transforming growth factor alpha Rattus norvegicus 125-134 7530605-7 1995 DEN-WY and WY abrogated the small amount of centrilobular TGF alpha staining observed in livers from control rats. Diethylnitrosamine 0-3 transforming growth factor alpha Rattus norvegicus 58-67 7530605-10 1995 An unexpectedly large proportion of EF induced by DEN-WY (6/38) and DEN-control (3/11) were TGF alpha-positive. Diethylnitrosamine 50-53 transforming growth factor alpha Rattus norvegicus 92-101 7530605-13 1995 TGF alpha over-expression noted in a significant proportion of EF was associated only with those regimens including DEN initiation. Diethylnitrosamine 116-119 transforming growth factor alpha Rattus norvegicus 0-9 17380077-0 2007 Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver. Diethylnitrosamine 58-76 transforming growth factor alpha Rattus norvegicus 41-50 32121064-10 2020 Moreover, SMSP administration suppressed the expressions of the target genes of TGF-beta and STAT3 induced by DEN treatment. Diethylnitrosamine 110-113 transforming growth factor alpha Rattus norvegicus 80-88 14742314-10 2004 Our results suggest that NIK-333 inhibits DEN-induced hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation. Diethylnitrosamine 42-45 transforming growth factor alpha Rattus norvegicus 98-107 14742314-0 2004 An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation. Diethylnitrosamine 39-59 transforming growth factor alpha Rattus norvegicus 116-125 14742314-8 2004 In addition, NIK-333 at the same doses decreased DEN-induced overexpression of TGF-alpha in hepatocellular neoplasms (adenomas and carcinomas) and their surrounding tissue. Diethylnitrosamine 49-52 transforming growth factor alpha Rattus norvegicus 79-88 10195348-0 1999 p53 expression and TGF-alpha-induced replication of hepatocytes isolated from rats exposed to the carcinogen diethylnitrosamine. Diethylnitrosamine 109-127 transforming growth factor alpha Rattus norvegicus 19-28 8806879-3 1996 The overall aim of this study was to characterize TGF alpha staining in diethylnitrosamine-induced hepatic foci from male F344 rats with the hematoxylin and eosin (H and E) histological phenotype. Diethylnitrosamine 72-90 transforming growth factor alpha Rattus norvegicus 50-59